G435-0914 Screening compound: ethyl 4-{1-[2-(4-butoxyphenyl)pyrazolo[1,5-a]pyrazin-4-yl]piperidine-4-carbonyl}piperazine-1-carboxylate

G435-0914 Screening compound: ethyl 4-{1-[2-(4-butoxyphenyl)pyrazolo[1,5-a]pyrazin-4-yl]piperidine-4-carbonyl}piperazine-1-carboxylate
G435-0914 Screening compound: ethyl 4-{1-[2-(4-butoxyphenyl)pyrazolo[1,5-a]pyrazin-4-yl]piperidine-4-carbonyl}piperazine-1-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound G435-0914
ethyl 4-{1-[2-(4-butoxyphenyl)pyrazolo[1,5-a]pyrazin-4-yl]piperidine-4-carbonyl}piperazine-1-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G435-0914

Molecular Formula

C29H38N6O4 (C29 H38 N6 O4)

Compound Name

ethyl 4-{1-[2-(4-butoxyphenyl)pyrazolo[1,5-a]pyrazin-4-yl]piperidine-4-carbonyl}piperazine-1-carboxylate

IUPAC name

ethyl 4-{1-[2-(4-butoxyphenyl)pyrazolo[15-a]pyrazin-4-yl]piperidine-4-carbonyl}piperazine-1-carboxylate

SMILES

CCCCOc(cc1)ccc1-c1nn(ccnc2N(CC3)CCC3C(N(CC3)CCN3C(OCC)=O)=O)c2c1

InChI

InChI=1S/C29H38N6O4/c1-3-5-20-39-24-8-6-22(7-9-24)25-21-26-27(30-12-15-35(26)31-25)32-13-10-23(11-14-32)28(36)33-16-18-34(19-17-33)29(37)38-4-2/h6-9,12,15,21,23H,3-5,10-11,13-14,16-20H2,1-2H3

InChI Key

XLIUPHBDNUDNSD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15014220

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

534.66

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.629

Distribution Coefficient, logD

4.627

Water Solubility, LogSw

-4.30

Polar Surface Area

70.121

Acid Dissociation Constant (pKa)

21.73

Base Dissociation Constant (pKb)

5.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

51.70

G435-0914 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with G435-0914 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G435-0914?
Check Price and Availability of G435-0914, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G435-0914 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G435-0914
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G435-0914
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G435-0914 available by request